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A B S T R A C T
Somatotyping is a practical technique for the description of physique. Individuals with Type 2 diabetes are character-
ized by physical peculiarities, such as overweight, obesity and a central pattern of body fat distribution. Somatotype ap-
plications to diabetes are limited. The objective of this study is to describe the somatotype of elderly type 2 diabetes pa-
tients. The sample consisted of 110 patients with type 2 diabetes (45 men, mean age 69.4±7.0 years; 65 women, mean age
72.9±7.1 years). The pathological subjects were compared with a control group consisting of 280 healthy individuals
(134 men, mean age 74.2±7.3 years; 146 women, mean age 74.9±7.4 years). The Heath-Carter somatotype was applied.
Diabetic men and women (mean somatotype, respectively: 6.8–5.6–0.6 and 8.6–6.4–0.2) presented significantly higher
values of endomorphy than the controls (p=0.043 in men, p=0.003 in women); men also had a lower mesomorphic com-
ponent (p=0.000). The somatotype method revealed physical peculiarities in type 2 diabetes patients. The marked endo-
morphy in the pathological individuals can be related to general fatness, which is a well known disease risk factor. The
somatotype appears to be a suitable technique for the assessment of physique in type 2 diabetes patients.
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Introduction
Somatotyping is an effective technique for the de-
scription of body shape and composition. An individual’s
somatotype is defined by three components named endo-
morphy, mesomorphy and ectomorphy. Endomorphy ex-
presses the level of fatness, mesomorphy the develop-
ment of the musculoskeletal compartment, ectomorphy
the linearity of the body. The photoscopic technique, de-
veloped by Sheldon et al.1, was subsequently modified by
other authors, with the definition of anthropometric
protocols2,3. The Heath-Carter somatotype method, cur-
rently the most widely used, is closely related to body
composition analysis, although the two approaches should
not be considered equivalent4–7.
Constitutional medicine represents a classical field of
application for somatotyping. Early studies, based main-
ly on the methodological approach of Sheldon and col-
legues1, have contributed to a better comprehension of
the mechanisms underlying the biological link between
physique and disease8. In more recent times, the soma-
totype method has been successfully applied to the study
of several risk factors and pathologies9–13.
Type 2 diabetes is a highly prevalent disease charac-
terized by peculiar variations in body size and shape. The
strong association between an excess of body fat, particu-
larly in the trunk, and this pathology was recognized in
early studies14 and is now widely documented15–18. How-
ever, as far as we know, somatotype applications to diabe-
tes are limited to a few papers published before the
1980s19–21.
The aim of this study is to describe physique varia-




The type 2 diabetes group consisted of 110 subjects
(65 women and 45 men) aged 65 to 90 years. The mean
age was 69.4±7.0 years for men and 72.9±7.1 years for
women. Patients were chosen from the Diabetes Service,
Geriatrics Division, SS. Trinità Hospital, ASL 8 of Cag-
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liari. The diagnosis of diabetes was made at admission to
the Diabetes Service according to the World Health Orga-
nization criteria22. When enrolled, they were being treat-
ed only with a diet (45 women and 22 men) or oral
hypoglycemic drugs (22 women and 14 men). None of the
patients was on insulin therapy.
The control group consisted of 280 healthy individu-
als (134 men and 146 women) aged 60 to 90 years. The
mean age was 74.2±7.3 years for men and 74.9±7.4
years for women. The sampling was performed in cul-
tural and recreational meeting places of the city of Cag-
liari (Italy). The subjects were questioned by means of a
structured interview about personal, behavioral and anam-
nestic information. Individuals who had been admitted
to hospital in the 3 months before the survey, or were un-
der medical treatment, were excluded from the sample.
All the selected participants were in good general health.
Somatotype characteristics of the control group are dis-
cussed in detail by Buffa et al.23.
All the type 2 diabetes and control individuals were
born and resident in the province of Cagliari (Italy), and
their Sardinian origin was verified to the first parental
generation. All subjects agreed to participate in the study
after being informed about the objectives and methods of
the research.
Anthropometry
All anthropometric data were collected by a highly
trained operator, in accordance with international stan-
dard procedures24. All measurements were taken on the
right side of the body. Height was measured with a porta-
ble anthropometer; individuals were asked to inhale de-
eply and maintain a fully erect position during the mea-
surement. Body weight was recorded to an accuracy of
0.1 kg using a movable spring scale. Minimum waist, hip,
flexed upper arm and calf circumferences were measured
with a metal anthropometric tape. Humerus and femur
breadths were measured with a sliding biepicondylar cal-
iper. Triceps, subscapular, supraspinale and medial calf
skinfolds were measured using a Holtain caliper (D.S.
Medica, Milan).
The BMI (Body Mass Index, Kg/m2) and WHR (Waist
to Hip Ratio) were calculated. Anthropometric soma-
totype ratings were computed following the indications
of Carter and Heath25.
Statistical analyses
Summary statistics of the anthropometric variables
were calculated in the pathological and control groups.
In the statistical comparison between the two groups
(sexes separated), we controlled for the potentially con-
founding effect of ageing by means of an analysis of
covariance design (ANCOVA) with age as the covariate.
As indicated by Carter et al.26, in each sex/health con-
dition group, we computed the descriptive statistics of
the somatotype (mean and standard deviation of the
component scores) and the somatotype attitudinal mean
(SAM), indicative of the dispersion of somatopoints. Fre-
quencies of subjects in each of somatotype categories
were also calculated.
Simple linear correlation analysis was applied to eval-
uate the relationship between the endomorphic compo-
nent and the indicators of overall body fatness (BMI) and
central adiposity (WHR and waist circumference).
To test the differences between patients and controls
(sexes separated), we used the statistical protocol pro-
posed by Cressie et al.27. A multivariate analysis of cova-
riance (MANCOVA), with age as a covariate, was applied
first. Then, the significance of each somatotype compo-
nent was determined by means of ANCOVA (controlled
for age). Finally, to evaluate which components provide
the greatest inter-group discrimination, we performed a
forward stepwise discriminant analysis.
The mean somatotypes of each group were plotted in
the somatochart.
The software packages Statistica 4.0 (Statsoft Inc.)
and Somatotype calculation and analysis28,29 were used
for the statistical analyses.
Results
The sex and age composition of the sample is shown
in Table 1. Table 2 shows the descriptive statistics and
results of the comparison between the pathological and
control groups for the anthropometric variables. Diabetic
individuals generally had higher body weight and BMI,
larger skinfolds and circumferences, and smaller breadths
than the control group.
Table 3 shows the descriptive statistics of the soma-
totype components and the results of the inter-group
comparisons. The mean somatopoints of each sex/health
condition group are represented graphically in Figure 1.
Table 4 shows the outputs of the discriminant analysis
for assessment of the relative contribution of each com-
ponent.
The mean somatotype of diabetic patients was 6.8–
5.6–0.6 (SD: 1.4–1.1–0.8) in men and 8.6–6.4–0.2 (SD:
1.6–1.7–0.3) in women. In the males, 68.0% of the soma-
topoints fell in mesomorphic endomorph, 16.0% in meso-
morph-endomorph, 16.0% in endomorphic mesomorph.
The SAM value was 1.77. In the females, 83.0% of the indi-
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TABLE 1
SEX AND AGE DISTRIBUTION
Age (y)
Diabetes Control
Men Women Men Women
60–69 28 24 36 40
70–79 12 31 67 66
+80 5 10 31 40
Total 45 65 134 146
60–69y – aged 60 to 69.99 years, 70–79y – aged 70 to 79.99 years,
+80y – over 80 years of age
vidual somatotypes were mesomorphic endomorph, 14.0%
mesomorph-endomorph, 3.0% endomorphic mesomorph.
The SAM index was 1.98.
The mean somatotype of the control group was 6.1–
6.3–0.6 (SD: 1.4–1.2–0.7) in men and 7.7–6.3–0.4 (SD: 1.4–
1.5–0.6) in women. In the males, 30.1% of the somatotypes
belonged to mesomorphic endomorph, 28.6% to mesomorph-
-endomorph, 40.6% to endomorphic mesomorph, 0.7% to
ectomorphic mesomorph. The SAM index was 1.67. In the
females, 69.9% of the subjects were mesomorphic endo-
morph, 20.5% mesomorph-endomorph, 8.9% endomorphic
mesomorph, 0.7% central. The SAM value was 2.05.
In both males and females of the diabetes and control
groups, the endomorphic component was significantly
related to the BMI (correlation coefficients ranging be-
tween 0.64 in the diabetic men and 0.73 in the healthy
women) and to the waist circumference (r-values be-
tween 0.47 in the diabetic men and 0.63 in the healthy
men). The association between endomorphy and WHR
was less evident, being significant only for the male con-
trol group (r= 0.38).
The comparison between diabetic individuals and
controls showed significant differences in both sexes
(MANCOVA, males: p=0.000; females: p=0.007) (Table
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TABLE 2
DESCRIPTIVE AND INFERENTIAL STATISTICS OF THE ANTHROPOMETRIC VARIABLES FOR THE COMPARISON
BETWEEN PATHOLOGICAL SUBJECTS AND CONTROLS1
Diabetes Control
Men Women Men Women
Mean SD Mean SD Mean SD Mean SD
Height 163.0 6.4 149.4 6.8 161.1 5.8 148.5 6.3
Weight 75.0 9.1 69.7* 13.7 72.3 11.0 63.6 13.3
Triceps sk 22.8* 7.6 32.2* 10.0 15.1 7.1 26.9 9.9
Subscapular sk 25.3* 7.7 29.4* 10.9 20.5 7.1 25.6 9.7
Supraspinale sk 24.3* 8.7 32.9* 11.6 26.4 9.0 27.8 10.3
Calf sk 19.0* 9.3 29.1 11.6 14.9 8.1 26.3 8.9
Humerus br 7.1* 0.4 6.3 0.5 7.2 0.4 6.4 0.5
Femur br 9.5* 0.5 9.0* 1.0 9.8 0.8 9.5 0.8
Upper arm crf 30.9 2.9 31.6* 4.6 30.7 3.1 29.5 4.0
Calf crf 34.9* 3.4 35.8* 4.4 35.1 3.0 33.9 3.7
Waist crf 95.8 7.1 95.9* 11.6 94.4 9.1 91.8 13.4
Hip crf 101.1 5.9 108.1 11.3 99.8 7.3 105.3 12.0
BMI 28.24 0.95 31.15* 5.34 27.80 3.69 28.75 5.18
WHR 0.95 0.05 0.87 0.13 0.95 0.06 0.87 0.07
1 statistical differences in anthropometric variables determined by ANCOVA, with age as the covariate (weight is expressed in kg;
skinfolds (sk) in mm; BMI in kg/m2; all other measurements are expressed in cm), * – p<0.05, SD – standard deviation, sk – skinfold,
br – breadth, crf – circumference, BMI – Body Mass Index, WHR – Waist to Hip Ratio
TABLE 3






Wilk’s ë F ratio p
Men
Somatotype – – 0.86 – 0.000
Endomorphy 6.8 1.4 6.1 1.4 – 4.16 0.043
Mesomorphy 5.6 1.1 6.3 1.2 – 18.71 0.000
Ectomorphy 0.6 0.8 0.6 0.7 – 0.49 0.485
Women
Somatotype – – 0.94 – 0.007
Endomorphy 8.6 1.6 7.7 1.4 – 9.02 0.003
Mesomorphy 6.4 1.7 6.3 1.5 – 0.02 0.895
Ectomorphy 0.2 0.3 0.4 0.6 – 2.79 0.096
1 – statistical differences in overall somatotype tested by MANCOVA, with age as the covariate; differences in somatotype components
determined by ANCOVA, with age as the covariate, SD – standard deviation, p – probability
3). In men, the difference was due to the endomorphic
component, higher in diabetic subjects than controls
(ANCOVA, p=0.043), and the mesomorphic component,
lower in diabetics (ANCOVA, p=0.000). In women, dif-
ferences were significant only in the case of endomorphy,
which was greater in the diabetic group (ANCOVA, p=
0.003). The forward stepwise discriminant analysis con-
firmed that endomorphy and mesomorphy greatly con-
tribute to inter-group diversification in both sexes (p=
0.000, males; p=0.003, females) (Table 4).
Discussion
Physical peculiarities of type 2 diabetes patients were
described in early somatometric studies, carried out in
the past half century. These studies showed that diabetes
patients have a tendency to endomorphy and an excess of
weight and body fat, particularly in the trunk13,19–21. It is
now widely accepted that overweight, obesity and a cen-
tral pattern of body fat distribution are major contribu-
tors to the development of type 2 diabetes15–18. Epidemio-
logical research has shown that a large proportion of the
prevalence of the disease (60–90%) is attributable to
these factors30. Patients with a BMI of 35 have a 92-fold
higher risk of developing type 2 diabetes31.
In the present study, the somatotype characteristics
of the diabetic individuals were significantly distinct
from those of the control group (Tables 3 and 4, Figure
1). There was strong development of the endomorphic
component in both diabetic men and women, as observed
in the previously mentioned specific literature19–21. A
similar development of endomorphy has been observed
in other studies on the somatotype of individuals with
pathologies correlated with diabetes, such as coronary
artery disease32 and metabolic risk factors9,10. In fact, it
has been suggested that endomorphy can be considered a
general indicator of the predisposition to various chronic
diseases11,33.
The convergence of the results of the somatotype and
other anthropometric techniques is remarkable. The val-
ues of endomorphy and anthropometric indicators of fat-
ness were particularly high in the pathological individu-
als. Moreover, the BMI and the waist circumference were
significantly related to endomorphy. In contrast, the
WHR was similar in the diabetes and control groups, and
it was not related to endomorphy. This suggests a lower
suitability of WHR as a risk factor, as observed in other
studies34.
Our study also showed lower mesomorphy in diabetic
men. This result does not agree with the literature.
Fredman20,21, applying both the Parnell and Heath-
-Carter anthropometric methods, found that diabetic
Tamil Indians tended to be more mesomorphic than
healthy individuals. This observation was corroborated
by Katzmarzyk et al.10 who showed that the mesomor-
phic component was associated with glycemia in females.
The inconsistency of results could be due to population
differences or to random fluctuations in the samples.
In conclusion, type 2 diabetes patients were charac-
terized by somatotypic peculiarities. Diabetic individuals
were more endomorphic and, in the case of men, less
mesomorphic. The development of endomorphy is in ac-
cordance with the literature and summarizes morpholog-
ical variations already known to play a role in health-re-
lated physical fitness. Somatotype can be considered a
suitable tool for the assessment of physical peculiarities
of pathological subjects. It has the advantage of provid-
ing concise, quantifiable and comparable data, and it
could be applied in the monitoring of health status in the
elderly population and in the planning of nutrition inter-
vention programs.
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TABLE 4
FORWARD STEPWISE DISCRIMINANT ANALYSES FOR DIFFERENCES IN SOMATOTYPE1
Diabetes vs. control Step 1 Step 2 Step 3 Wilk’s ë p
Men Mesomorphy (12.26) Endomorphy (15.32) Ectomorphy (0.16) 0.86 0.000
Women Endomorphy (10.65) Mesomorphy (3.33) Ectomorphy (0.15) 0.94 0.003
1 – F–value to enter is given in parentheses. Wilk’s lambda and p–values refer to the discriminant function with Endo-, Meso- and
Ectomorphy considered in the model, p – probability
Fig. 1. Somatocharts with mean somatotypes in Type 2 diabetes
patients and controls. () – men, () – women.
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SOMATOTIP KOD STARIJIH PACIJENATA KOJI BOLUJU OD DIJABETESA TIPA 2
S A @ E T A K
Somatotipiziranje je uobi~ajna tehnika za opisivanje fizi~kih osobina. Za osobe oboljele od dijabetesa tipa 2, karakte-
risti~ni su pretilost i centralizacija tjelesnih masno}a. Somatotipske aplikacije za dijabetes su ograni~ene. Predmetnost
ove studije je opisati somatotip kod starijih pacijenata koji boluju od dijabetesa tipa 2. Uzorak je sadr`avao 110 pacije-
nata (45 mu{kih, prosjek godina 69.4±7.0; 65 `ena, prosjek godina 72.9±7.1). Patolo{ki subjekti uspore|ivani su sa
kontrolnom grupom od 280 zdravih osoba (134 mu{kih, prosjeka godina 74.2±7.3; 146 `ena prosjeka godina 74.9±7.4).
U studiji je primjenjena »Heath-Carter« somatotipizacija. Dijabeti~ari oba spola (prosje~nog somatotipa: 6.8–5.6–0.6 i
8.6–6.4–0.2) pokazivali su zna~ajno visoke endomorfi~ne vrijednosti u odnosu na kontrolnu skupinu (p=0.043 kod mu{-
karaca, p=0.003 kod `ena). Metoda somatotipizacije otkrila je fizi~ke osobitosti kod pacijenata oboljelih od dijabetesa
tipa 2. Generalno, morfologiju oboljelih mo`emo povezati sa debljinom. Somatotipizacija bi trebala biti standardna
tehnika u odre|ivanju fizi~kih osobina kod dijabeti~ara.
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